InvestorsHub Logo
Followers 30
Posts 3306
Boards Moderated 0
Alias Born 08/21/2015

Re: georgejjl post# 188404

Friday, 04/05/2019 6:19:16 PM

Friday, April 05, 2019 6:19:16 PM

Post# of 458346
FDA will not approve 2-73 based on this data. But this data and the demographic and biologic profiles of each patient will help 2-73 design a large phase 3 with efficacy in mind. I’m not denying what had happened, but acknowledging that it is limited and is preliminary in nature (unblinded with no placebo, etc.).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News